Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)-Reference-Cited by-同舟云学术

Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715)

Published:1995-11 Issue:3 Volume:52 Page:621-627
ISSN:0091-3057
Container-title:Pharmacology Biochemistry and Behavior
language:en
Short-container-title:Pharmacology Biochemistry and Behavior

Author:

Layer Richard T.,Popik Piotr,Olds Tia,Skolnick Phil

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Biological Psychiatry,Clinical Biochemistry,Pharmacology,Toxicology,Biochemistry

Reference52 articles.

1. Inhibition of rat brain monoamine oxidase activity by cerebral anti-ischemic agent, ifenprodil;Arai;Neuropharmacology,1991

2. Ifenprodil and SL 82. 0715 as cerebral antischemic agents. II. Evidence for N-ethyl-d-aspartate receptor antagonist properties;Carter;J. Pharmacol. Exp. Ther.,1988

3. Ifenprodil and SL 82. 0715 are antagonists at the polyamine site of the N-methyl-d-aspartate (NMDA) receptor;Carter;Eur. J. Pharmacol.,1989

4. Seperation of α1 adrenergic and N-methyl-d-aspartate antagonist activity in a series of ifenprodil compounds;Chenard;J. Med. Chem.,1991

5. Ifenprodil and SL 82. 0715 potently inhibit binding of [3H](+)-3-PPP to σ binding sites in rat brain;Contreras;Neurosci. Lett.,1990

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The N -methyl- d -aspartate receptor hypothesis of ketamine’s antidepressant action: evidence and controversies;Philosophical Transactions of the Royal Society B: Biological Sciences;2024-06-10

2. Subanesthetic S‐ketamine does not acutely alter striatal dopamine transporter binding in healthy Sprague Dawley female rats;Synapse;2024-05-30

3. The Role of Vesicle Release and Synaptic Transmission in Depression;Neuroscience;2022-11

4. A systematic review of studies investigating the acute effects of N-methyl-D-aspartate receptor antagonists on behavioural despair in normal animals suggests poor predictive validity;Brain and Neuroscience Advances;2022-01

5. Translational Neuropsychopharmacology for Major Depression: Targeting Neurotransmitter Systems;Neuromethods;2022